Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-052-1 | CAS number: 68186-90-3 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77310.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute toxicity via oral route:
oral LD50 rat > 10000 mg/kg bw (standardized test protocol; BASF 1978)
Acute toxicity via inhalation route:
Not relevant
Acute toxicity via dermal route:
No mortality or systemic toxicity was observed in a 7-h inhalation hazard test (IHT, BASF, 1978) and in a 5-d bioavailability study (BASF, 33I0110/91008, 1994; see section 7.5.2).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- BASF test: The study was conducted according to an internal BASF method which in principle is comparable to the OECD Guideline 401. A test group consisting of 10 animals/sex was treated by single gavage with an aqueous suspension of the test substance. The animals were observed for mortality and for clinical symptoms of toxicity. They were weighed prior to treatment only. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Fasting period before study: 16 h
- Housing: Makrolon Typ III (maximum 5 animals per cage)
- Diet: standard pellet diet for mice and rats, ad libitum
- Water: ad libitum
- Acclimation period: 3-7 d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-1
- Humidity (%): 55+/-10
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.5%
MAXIMUM DOSE VOLUME APPLIED: 31.6 mL/kg - Doses:
- 10000 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were performed within the first 15 min after application and 30 min, 1 h, 2 h, 4 h, 5 h, 24 h after application; subsequently at least once daily. Animals were weighed directly before the application.
- Necropsy of survivors performed: yes - Statistics:
- not performed
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- none
- Clinical signs:
- other: Nothing abnormal observed.
- Gross pathology:
- Nothing abnormal observed.
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 10 000 mg/kg bw
- Quality of whole database:
- Guideline compliant study.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity via oral route:
Key study:
For the oral exposure pathway a limit test is available, performed according to a standardized internal method, which is in principle comparable to the OECD guideline 401, but for which GLP compliance was not confirmed (BASF 1978). Since there were no mortalities, clinical signs or necropsy findings observed in male and female rats dosed with 10000 mg/kg bw after the 14 d observation period, the acute oral LD50 is > 10000 mg/kg bw and the LD0 is ≥ 10000 mg/kg bw in rats.
Supporting studies:
The result of the key study is supported by two supporting studies, which reveled an LD50 >5000 mg/kg and >10000 mg/kg (Ishihara Sangyo Kaisha 1985; Bayer 1972).
Acute toxicity via dermal route:
No data were available for acute dermal toxicity. In accordance with Regulation (EC) 1907/2006 (REACH), the acute dermal route was waived as the substance does not meet the criteria for classification as acute toxicity or STOT SE by the oral route (LD50 >2000 mg/kg, see section 7.2.1). Additionally, no systemic effects have been observed in the in vivo studies with dermal exposure (see section 7.3.1).
Acute toxicity via inhaltion route:
For the acute inhalation via the inhalation route two studies were considered in a weight of evidence approach. An acute inhalation hazard test (IHT), performed in principle as described in the OECD Guideline 403, is available (BASF, 1978). In this study, rats were exposed for a period of 7 hours to an atmosphere saturated with vapors of the volatile components of the test substance at 20 °C. No mortality was observed during this test.
Additionally, a valid subacute inhalation study was performed in rats only with an analogous substance, the nickel rutile. In a GLP compliant bioavailability study, male Wistar rats were exposed for 5 d to 60 mg/m³ of the test substance; the observation period was 0, 3, 10, 31 and 60 d (BASF, 33I0110/91008, 1994). No effects on mortality, clinical signs, body weights and body weight gains were found. Clearance half time was approximately 50 d in the lung. The study was not able to demonstrate bioavailability after inhalation of the test substance.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. Based on the available toxicity data and the physical-chemical properties of the test substance, it is not classified according to Regulation (EC) No 1272/2008 (CLP), as amended for the ninth time in Regulation (EC) No 2016/1179.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
